Edwards Lifesciences reported $645.7M in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Atricure ATRC:US USD 46K 0
Baxter International BAX:US USD 683M 0
Becton, Dickinson and BDX:US USD 365M 0
Boston Scientific BSX:US USD 17M 0
Cardiovascular Systems CSII:US USD 40K 0
Cooper Companies COO:US USD 5.4M 0
Cryolife CRY:US USD 418K 1000
Dexcom DXCM:US USD 400K 0
Edwards Lifesciences EW:US USD 645.7M 700K
Globus Medical GMED:US USD 99K 0
Hologic HOLX:US USD 3M 0
Icu Medical ICUI:US USD 2.4M 8K
Insulet PODD:US USD 100K 0
Integra Lifesciences IART:US USD 903K 0
Masimo MASI:US USD 100K 0
Medtronic MDT:US USD 133K 0
Merit Medical Systems MMSI:US USD 658.2M 6.27M
Nuvasive NUVA:US USD 63K 0
Stryker SYK:US USD 38M 0
Tandem Diabetes Care TNDM:US USD 64K 0
Teleflex TFX:US USD 47.94M 1000
Zimmer Biomet Holdings Inc ZBH:US USD 3.1M 0